Cargando…

PW02-041 - Canakinumab treatment regimens in CAPS-patients

Detalles Bibliográficos
Autores principales: Hofer, F, Endres, T, Kortus-Götze, B, Blank, N, Weißbarth-Riedel, E, Schuetz, C, Kallinich, T, Krause, K, Rietschel, C, Horneff, G, Kuemmerle-Deschner, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952126/
http://dx.doi.org/10.1186/1546-0096-11-S1-A182
_version_ 1782307169733967872
author Hofer, F
Endres, T
Kortus-Götze, B
Blank, N
Weißbarth-Riedel, E
Schuetz, C
Kallinich, T
Krause, K
Rietschel, C
Horneff, G
Kuemmerle-Deschner, J
author_facet Hofer, F
Endres, T
Kortus-Götze, B
Blank, N
Weißbarth-Riedel, E
Schuetz, C
Kallinich, T
Krause, K
Rietschel, C
Horneff, G
Kuemmerle-Deschner, J
author_sort Hofer, F
collection PubMed
description
format Online
Article
Text
id pubmed-3952126
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39521262014-03-24 PW02-041 - Canakinumab treatment regimens in CAPS-patients Hofer, F Endres, T Kortus-Götze, B Blank, N Weißbarth-Riedel, E Schuetz, C Kallinich, T Krause, K Rietschel, C Horneff, G Kuemmerle-Deschner, J Pediatr Rheumatol Online J Meeting Abstract BioMed Central 2013-11-08 /pmc/articles/PMC3952126/ http://dx.doi.org/10.1186/1546-0096-11-S1-A182 Text en Copyright © 2013 Hofer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Hofer, F
Endres, T
Kortus-Götze, B
Blank, N
Weißbarth-Riedel, E
Schuetz, C
Kallinich, T
Krause, K
Rietschel, C
Horneff, G
Kuemmerle-Deschner, J
PW02-041 - Canakinumab treatment regimens in CAPS-patients
title PW02-041 - Canakinumab treatment regimens in CAPS-patients
title_full PW02-041 - Canakinumab treatment regimens in CAPS-patients
title_fullStr PW02-041 - Canakinumab treatment regimens in CAPS-patients
title_full_unstemmed PW02-041 - Canakinumab treatment regimens in CAPS-patients
title_short PW02-041 - Canakinumab treatment regimens in CAPS-patients
title_sort pw02-041 - canakinumab treatment regimens in caps-patients
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952126/
http://dx.doi.org/10.1186/1546-0096-11-S1-A182
work_keys_str_mv AT hoferf pw02041canakinumabtreatmentregimensincapspatients
AT endrest pw02041canakinumabtreatmentregimensincapspatients
AT kortusgotzeb pw02041canakinumabtreatmentregimensincapspatients
AT blankn pw02041canakinumabtreatmentregimensincapspatients
AT weißbarthriedele pw02041canakinumabtreatmentregimensincapspatients
AT schuetzc pw02041canakinumabtreatmentregimensincapspatients
AT kallinicht pw02041canakinumabtreatmentregimensincapspatients
AT krausek pw02041canakinumabtreatmentregimensincapspatients
AT rietschelc pw02041canakinumabtreatmentregimensincapspatients
AT horneffg pw02041canakinumabtreatmentregimensincapspatients
AT kuemmerledeschnerj pw02041canakinumabtreatmentregimensincapspatients